WASHINGTON, D.C.—Intensity-modulated radiotherapy (IMRT) has largely replaced 3D external beam radiotherapy (EBRT) as the preferred radiation treatment for localized prostate cancer (PCa), according ...

EBRT with or without STAD showed similar 15-year PCSS and OS rates in IRPC patients, with high PSA failure rates observed. Multivariate analysis indicated greater side effects in the STAD group ...

EBRT plus brachytherapy does not improve outcomes over brachytherapy alone in patients with intermediate-risk prostate cancer, a phase 3 trial suggests. External beam radiation therapy (EBRT) plus ...

Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk prostate cancer treated with external-beam radiation therapy (EBRT), ...

NRG-RTOG 0232 randomly assigned588 men with intermediate-risk prostate cancer to either the COMBO or the BT treatment arm and 579 were eligible/analyzed. The COMBO arm consisted of 287 patients versus ...

If you have prostate cancer and radiation therapy is an option, how to choose which type is right for your situation? The answer lies in a discussion with your doctor about the pluses and minuses of ...

Patients with prostate cancer who were treated with brachytherapy boost showed improved survival compared with those treated with external beam radiotherapy in a recent study. Brachytherapy boost (BTB ...

Patients with metastatic castration-resistant prostate cancer previously treated with external beam radiation therapy did not increase incidence of blood-related side effects with radium-223 compared ...

Prostate brachytherapy is widely used to treat patients with low-risk prostate cancer, but its use in patients at high risk of extracapsular cancer extension (ECE) is controversial. Dattoli and ...

Many patients with clinically localized prostate cancer who undergo local therapy develop biochemical failure, possibly due to metastatic disease. Gulley et al. investigated whether a vaccine encoding ...

Prostate cancer patients undergoing localized external beam radiation therapy (EBRT) can experience a progressive increase in fatigue, which can affect physical functioning and quality of life. The ...